Veraxa Biotech Holding AG (VRXA) Invested Capital (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Invested Capital for 2 consecutive years, with -$123.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital fell 48410.63% year-over-year to -$123.2 million; the trailing twelve-month figure through Dec 2025 stood at -$123.2 million (down 48410.63% YoY), and the FY2025 full-year result was -$123.2 million, down 48410.63% from the prior year.
• Invested Capital fell to -$123.2 million in Q4 2025 per VRXA's latest filing, from -$253992.0 in the prior quarter.
• In the past five years, Invested Capital ranged from a high of -$253992.0 in Q4 2024 to a low of -$123.2 million in Q4 2025.